Thursday, January 26, 2023

Nike Challenges Trademark of Hemp Company Slogan ‘Just Hemp It’

Nike is one of the largest footwear and athletic gear companies in the world, known for its familiar slogan “Just Do It.” The company recently issued a trademark complaint on Jan. 18 against a Texas-based CBD company called Revive Farming Technologies, who filed to use the trademark “Just Hemp It” on Dec. 16, 2019.

“JUST DO IT … which has been in use in commerce for more than 30 years, and registered for more than 25 years, is famous within the meaning of Lanham Act Section 43(c), 15 USC § 1125(c),” Nike stated. It is asking the Patent and Trademark Office and Trademark Trial and Appeal Board to deny Revive’s attempt to trademark the phrase “Just Hemp It.”

Nike argues that it owns multiple trademark registrations for the “Just Do It” mark, describing it as “widely recognized and famous,” and that the Revive should not be allowed to trademark “Just Hemp It” because it would lead to confusion and cause injury and damage to Nike.

According to Green Market Report (GMR), Revive already features the phrase on its website followed with a trademark symbol. GMR also states that the website contains language that makes unauthorized medical claims about CBD.

Nike’s “Just Do It” campaign first launched in 1988 by the late Dan Wieden, who has successfully launched other slogan campaigns for companies like Old Spice, Procter and Gamble, and Coca Cola. Apparently Wieden said that “Just Do It” was inspired by the final words of an inmate on death row, who said “You know, let’s do it” before his execution.

Nike has led successful trademark complaints against other companies attempting to use variations of “Just Do It” in the past. In 1992, Nike targeted a company called “Just Did It,” which also sold athletic gear, for trademark infringement. In 2020, Nike went after a business for using “Just Believe It.” More recently, a small business owner who started a succulent shop called JustSuccIt in 2020, was also contacted by Nike regarding trademark infringement.

This hasn’t been an uncommon trend in the cannabis industry either. In August 2017, the glue company known as Gorilla Glue took Gorilla Glue Strains to court. The results meant that strains known as Gorilla Glue #1 or Gorilla Glue #4 would be referred to as GG1 or GG4. 

In February 2018, The Hershey Co. began suing cannabis companies for copyright infringement, and targeted both the Oakland-based Harborside dispensary and a California edibles company called Good Girl Cannabis Co. for selling items with similar Hershey product branding.

UPS targeted cannabis delivery services that were using its acronym, such as United Pot Smokers, UPS420, and THCPlant in February 2019. 

Later in August 2019, Sour Patch Kids targeted illegal cannabis products like Stoney Patch for infringing upon the trademark as well. Cinnabon took on a vape company in October 2019 for selling an e-liquid using the brand’s name, just one month before the Center for Disease Control and Prevention discovered that vaping lung injuries were being caused by vitamin E acetate in November 2019.

More recently in August 2022, Mars Wrigley won a lawsuit against cannabis companies using the logo font and colors to sell illegal edibles. “I have placed significant weight on the issue of harm not only to the Plaintiff but also to members of the public who might accidentally consume the Defendants’ Infringing Product believing it to be a genuine SKITTLES product. The fact that SKITTLES are a confectionary product that are attractive to children reinforces the need to denounce the Defendants’ conduct,” said Judge Patrick Gleeson in his ruling.

The post Nike Challenges Trademark of Hemp Company Slogan ‘Just Hemp It’ appeared first on High Times.



from The Latest Marijuana News Today | HighTimes Magazine https://hightimes.com/news/nike-challenges-trademark-of-hemp-company-slogan-just-hemp-it/?utm_source=rss&utm_medium=rss&utm_campaign=nike-challenges-trademark-of-hemp-company-slogan-just-hemp-it
via IFTTT

Wednesday, January 25, 2023

History made: Mississippi’s first medical marijuana dispensaries open for business

The first of 162 state-licensed dispensaries opened on Wednesday afternoon.

The post History made: Mississippi’s first medical marijuana dispensaries open for business appeared first on Leafly.



from Leafly https://ift.tt/cTLBv90
via IFTTT

The world’s best cannabis seeds and clones to grow in 2023

Let’s grow a pound.

The post The world’s best cannabis seeds and clones to grow in 2023 appeared first on Leafly.



from Leafly https://ift.tt/NCt5PI6
via IFTTT

Death of a Trimmer (Part 2): A shocking death reveals serious health hazards in the cannabis industry

Lorna McMurrey's death raises questions about asthma and brown lung disease in the cannabis industry. Who's looking out for workers on the factory floor?

The post Death of a Trimmer (Part 2): A shocking death reveals serious health hazards in the cannabis industry appeared first on Leafly.



from Leafly https://ift.tt/fqLJbwR
via IFTTT

New York Cannabis: State of the State 2023

A lot has happened in New York since the Canna Law Blog’s first New York State of the State. Last year was action-packed for the cannabis industry in New York. With licenses issued and sales starting in 2022, New York got the ball rolling on an actual and legal cannabis industry. We expect 2023 will see even more progress as we push towards New York having a fully functioning cannabis industry. Let’s take a look at the noteworthy developments of 2022 and what we expect to see in 2023.

Three big developments in 2022

1.  New York issued (conditional) adult-use cannabis licenses

A legal adult-use cannabis industry requires licenses to be issued. New York took that significant first step by issuing conditional cultivation, processing and retail dispensary licenses. While we encourage you to read our detailed breakdowns of the three license types, here’s a brief refresher on the specifics.

On April 14, 2022, the Cannabis Control Board (CCB) and Office of Cannabis Management (OCM) issued 52 conditional adult-use cultivation licenses. These licenses were limited to existing licensed (or almost licensed) hemp cultivators. The OCM continued to issue more conditional cultivation licenses after the first batch was announced, beginning the tangible development of the production “tier” of New York’s cannabis industry. On August 17, 2022, New York approved 15 adult-use conditional processor licenses, with the requirements for licensure generally tracking those for the conditional cultivator licenses. More conditional cultivation and processing licenses have been issued since.

On November 21, 2022, the CCB and OCM announced the first Conditional Adult-Use Retail Dispensary (CAURD) licenses that would be issued, with the announced goal of beginning sales by the end of 2022.

2. New York opens its first licensed cannabis dispensary

A cannabis industry doesn’t mean much until consumers can begin purchasing legal cannabis. New York’s momentous step into the legal cannabis sale took place on December 29, 2022, when Housing Works (one of the CAURD licensees) opened its adult-use retail dispensary.

Housing Works’ opening was met with much fanfare and has continued to attract customers and media attention. More legal dispensaries are on the horizon, but 2022 was notable if only for the fact that actual legal sales started in New York!

3.  New York released adult-use cannabis rules and regulations

On the same day the CCB announced the first CAURD license awardees, it also released its full set of adult-use cannabis rules and regulations. We have covered it here; the rules and regulations will be part of our ongoing series.

We cannot overstate the significance of these rules and regulations. They set the overall framework of the licensing process and the industry as a whole, establishing the baseline analysis for anyone who considers applying for an adult-use cannabis license in New York.

Three big things we expect to see in 2023

1.  Shutdown of illegal retail dispensaries

The hottest topic in New York’s cannabis industry (particularly in New York City) is the prevalence of illegal cannabis dispensaries. The New York City Council has identified at least 1,200 illicit dispensaries. Multiple government officials and agencies have discussed clamping down on illegal activities since the MRTA was passed in April of 2021.

The prevalence of easily accessible unlicensed cannabis products is, in our opinion, the single biggest threat to New York’s nascent legal cannabis industry. The MRTA  established a two-tier system that is intended to create a competitive industry with lots of room for small businesses. Illegal dispensaries, which are not subject to taxes, testing or the myriad costly compliance obligations that legal business must pay for, will undercut the legal market if allowed to run rampant. See: California.

The New York City Council has announced plans to significantly increase enforcement to crack down on illegal dispensaries, but it remains to be seen what steps will actually be taken, and if those efforts will actually work.

2.  More dispensaries will open

The first batch of CAURD licenses included 36 licensees. Since the first licensees were announced in November, only Housing Works has opened its doors. That’s going to change soon.

Smacked LLC, the first CAURD licensing owned by an individual, will be opening the second licensed cannabis dispensary in Greenwich Village (Manhattan). More dispensaries are expected to open over the next few months, a development which was likely made possible by the CCB and OCM easing the real estate selection regulations for CAURD licensees.

3.  Non-conditional license applications will open (we hope)

New York’s release of the adult-use rules and regulations was the necessary precursor to New York opening its application portal for all of the MRTA’s enumerated license types (cultivation, processing, distributions, microbusiness, dispensary, etc.). But with no application portal date announced, the public comment period still being open and the possibility of material changes to the current version of the rules and regulations, our hopeful target of spring 2023 for applications being accepted is looking overly optimistic.

The good thing is that the OCM and CCB appear to be taking the public comment process seriously, soliciting as much input from the cannabis industry as possible to have a final set of rules and regulations that creates an adult-use cannabis framework that actually works. The downside to that collaboration is the time it takes to receive and process public input. We hope that public comment will be received an processed efficiently, so that New York is able to continue building out a fully functioning cannabis industry in 2023.

The big picture

We have been and continue to be extremely optimistic about where New York’s cannabis industry is going. Starting licensing and sales was a big deal. Having actual adult-use rules and regulations to review and comment on was a big deal. The industry having an open dialogue with the OCM and CCB about what New York’s cannabis industry should look like is a big deal. Here’s to hoping that New York continues to progress in successfully expanding its cannabis industry in 2023!

The post New York Cannabis: State of the State 2023 appeared first on Harris Bricken Sliwoski LLP.



from Canna Law Blog™ https://ift.tt/iLI0sdJ
via IFTTT

Elon Musk Denies 420 Tweet Was About Weed

During a California court appearance Monday, when questioned about a 420 tweet, Elon Musk suddenly forgot the significance of the number in pot culture. The tech billionaire responded after being cornered by a prosecutor representing Tesla employees for a class action lawsuit alleging he tweeted and misled shareholders about the price of Tesla shares.

The fiasco began several years ago. In 2018, Musk rounded up Tesla shares from $419 to $420, announcing his plan to go private in a tweet. “Am considering taking Tesla private at $420,” Musk tweeted on Aug. 7, 2018. “Funding secured.”—sending officials from The Securities and Exchange Commission (SEC) into a tailspin.

Musk said he tweeted the share price based on what he said was a “firm commitment” from Saudi Arabia’s Public Investment Fund (PIF) to take Tesla private. But about 10 days later, Musk admitted that the Tesla buyout he had envisioned wasn’t going to materialize.

After an investigation, the SEC fined Musk $40 million, forcing the billionaire to step down as chair of Tesla’s board. The SEC said that Musk misled investors. In the SEC’s complaint, Musk was accused of rounding up the share price to $420 from $419 “because he had recently learned about the number’s significance in marijuana culture.” 

Musk caused instantaneous uproar about a month later, sparking a blunt with Joe Rogan on his show “The Joe Rogan Experience” on Sept. 3, 2018, shocking Tesla investors and officials across the board. His troubles didn’t end there. High Times asked if it was “the most expensive blunt of all time” due to the fallout, with NASA- and SpaceX-associated officials reviewing his security clearance.

The Verge reports that Nicholas Porritt is an attorney for a class of Tesla investors suing Musk for millions of dollars that they say resulted from his failure to take Tesla private. 

The courtroom got tense: “You rounded up to 420 because you thought that would be a joke that your girlfriend will enjoy, isn’t that correct?” Porritt asked. “No,” Musk said, adding, “there is some, I think, karma around 420. I should question whether that is good or bad karma at this point.”

Musk said that 420 wasn’t a weed joke, but a roughly 20% premium on the $419 stock price at the time. “420 was not chosen because of a joke,” Musk testified. “It was chosen because there was a 20 percent premium over the stock price.” Musk also claimed that it was a “coincidence.”

The jury will decide if Musk should have to pay out up to billions of dollars in damages to Tesla shareholders for the money they lost due to his tweets.

Judge Edward Chen ruled that the jury should be aware that Musk’s 2018 tweets are false. Jurors will now need to decide whether Musk deceived Tesla shareholders because of his tweets.

Musk said that he was not relying on a commitment for the Saudi PIF when he tweeted “funding secured,” adding that his shares in SpaceX would also help fund the deal to take Tesla private. “Just as I sold stock in Tesla to buy Twitter… I didn’t want to sell Tesla stock, but I did sell Tesla stock,” Musk said. “My SpaceX shares alone would have meant that funding was secured.”

Musk has also been sued by a group of former Twitter employees after a mass firing. Musk recently became the CEO of Twitter after buying the platform for $44 billion in October 2022. Saudi Prince Alwaleed bin Talal bin Abdulaziz is Twitter’s second-largest shareholder after Musk. 

The post Elon Musk Denies 420 Tweet Was About Weed appeared first on High Times.



from The Latest Marijuana News Today | HighTimes Magazine https://ift.tt/kWCHcVp
via IFTTT

Nevada Releases Bulletin for Products Affected by Unapproved Pesticide

The Nevada Cannabis Compliance Board (CCB) recently issued a public health and safety bulletin on Jan. 19 regarding the use of an unapproved pesticide. “The CCB was notified that the following cannabis and cannabis products had been treated with an unapproved pesticide, Ethephon, at Clark Natural Medicinal Solutions, LLC,” the CCB explained in its bulletin.

Currently, there are no illnesses reported, according to the bulletin.

The pesticide was applied sometime between July 23, 2021 and Jan. 5, 2023, and the CCB instructs consumers to check the labels of the cannabis they purchased (which includes flower, shake or trim, and pre-rolls). “All cannabis products properly sold by a licensed cannabis sales facility should have a product label on the packaging,” the CCB wrote. “The name of the cultivation facility which grew the cannabis and the harvest date can be found on the label, typically near the top.”

The CCB also put together a list of products that may have been affected by the pesticide, including more than 117 edibles, 41 infused pre-rolls, and more than 200 concentrates, sold at 104 dispensaries.

According to the U.S. Environmental Protection Agency, Ethephon was discovered in 1965 and registered as a pesticide in 1973. “Ethephon is a plant growth regulator used to promote fruit ripening, abscission, flower induction, and other responses,” the EPA states. “Ethephon is registered for use on a number of food, feed and nonfood crops, greenhouse nursery stock, and outdoor residential ornamental plants, but is used primarily on cotton. Formulations include formulation intermediates and soluble concentrates/liquids.”

The EPA also states that Ethephon can potentially cause severe skin and eye irritation “but otherwise is “moderately acutely toxic.”

The CCB also stated that testing facilities do not currently test for Ethephon specifically. “There is no reason to believe the cannabis sales facilities or cannabis testing facilities had any knowledge of the use of this unapproved pesticide; Ethephon is not on the list of pesticides the testing facilities must look for, and their test methods are not set up for detection of Ethephon.”

According to the Nevada Department of Agriculture, updated as of August 2022, there are 86 pesticides that are not legally prohibited to be used on cannabis plants. This varies from minimum risk ingredients such as cinnamon, garlic oil, or zinc metal strips to registered pesticides, such as myclobutanil, where “tolerance is monitored.”

Previously, the CCB has only issued a few safety bulletins such as this one. One bulletin was issued in 2020, which addressed failed microbial testing. Three were issued in 2021, involving more failed microbial testing, incorrect THC potency testing, and products that were unable to be verified as tested. Two bulletins were issued in 2022, pertaining to unverifiable testing and mislabeled products.

In addition to these bulletins, the CCB awarded the final licenses for consumption lounges in Nevada in December 2022, half of which were designated for social equity applicants. Funding for consumption lounges were initially approved in August 2021, with regulations approved by legislators in June 2022, such as safety protocols, staff training, and location restrictions. Now, consumption lounges are “likely to open before Summer 2023,” states the CCB.

One judge issued a ruling last year asking that cannabis be removed from the Schedule 1 category of the Controlled Substances Act. In September 2022, Judge Joe Hardy ordered the Nevada Board of Pharmacy to remove cannabis from its current schedule designation, because cannabis has been recognized in the Nevada constitution as having medical value. “The constitutional right to use marijuana upon the advice of a physician does establish that marijuana has an accepted medical use and treatment in the United States,” said Hardy.

The post Nevada Releases Bulletin for Products Affected by Unapproved Pesticide appeared first on High Times.



from The Latest Marijuana News Today | HighTimes Magazine https://ift.tt/3F2YrAZ
via IFTTT